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Abstract
Background: The objectives of this systematic review, commissioned by WHO, were to assess the frequency and severity of
clinical manifestations of human brucellosis, in view of specifying a disability weight for a DALY calculation.
Methods/Principal Findings: Thirty three databases were searched, with 2,385 articles published between January 1990–
June 2010 identified as relating to human brucellosis. Fifty-seven studies were of sufficient quality for data extraction.
Pooled proportions of cases with specific clinical manifestations were stratified by age category and sex and analysed using
generalized linear mixed models. Data relating to duration of illness and risk factors were also extracted. Severe
complications of brucellosis infection were not rare, with 1 case of endocarditis and 4 neurological cases per 100 patients.
One in 10 men suffered from epididymo-orchitis. Debilitating conditions such as arthralgia, myalgia and back pain affected
around half of the patients (65%, 47% and 45%, respectively). Given that 78% patients had fever, brucellosis poses a
diagnostic challenge in malaria-endemic areas. Significant delays in appropriate diagnosis and treatment were the result of
health service inadequacies and socioeconomic factors. Based on disability weights from the 2004 Global Burden of Disease
Study, a disability weight of 0.150 is proposed as the first informed estimate for chronic, localised brucellosis and 0.190 for
acute brucellosis.
Conclusions: This systematic review adds to the understanding of the global burden of brucellosis, one of the most
common zoonoses worldwide. The severe, debilitating, and chronic impact of brucellosis is highlighted. Well designed
epidemiological studies from regions lacking in data would allow a more complete understanding of the clinical
manifestations of disease and exposure risks, and provide further evidence for policy-makers. As this is the first informed
estimate of a disability weight for brucellosis, there is a need for further debate amongst brucellosis experts and a
consensus to be reached.
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Introduction
Brucellosis is one of the most common zoonotic infections
globally [1]. This bacterial disease causes not only a severely
debilitating and disabling illness, but it also has major economic
ramifications due to time lost by patients from normal daily
activities [2] and losses in animal production [3]. In a review of 76
diseases and syndromes of animals, brucellosis lies within the top
ten in terms of impact on impoverished people [4]. A brucellosis
disability weighting of 0.2 has been previously proposed for
Disability-Adjusted Life Years (DALY) calculation, based on the
pain and impaired productivity known to result from infection [3].
However, a more informed estimate is needed for an accurate
assessment of disease burden.
In 1992, the World Bank commissioned the original Global
Burden of Disease (GBD) study, providing a comprehensive
assessment of 107 diseases and injuries and 10 risk factors in eight
major regions [5]. This review did not include any neglected
tropical zoonoses. Such diseases often do not attract the interest of
health researchers or sufficient resources for adequate control, yet
they continue to impact significantly on human health and
wellbeing, livestock productivity, and local and national economies
[6]. There is a need for more accurate data relating to the burden
of neglected zoonoses to facilitate more effective implementation
of disease control interventions. In 2009, the Foodborne Disease
Burden Epidemiology Reference Group (FERG) of the World
Health Organization (WHO) commissioned a series of systematic
reviews on the burden of neglected zoonotic diseases, with the aim
of incorporating the findings into the overall global burden of
disease assessments.
This report presents a systematic review of scientific literature
published between 1990–June 2010 relating to morbidity from
human brucellosis infection. The objectives of this review were to
assess the frequency and severity of the clinical manifestations of
brucellosis, the duration of disease, the associated disabilities and
important risk factors, with a view to estimating an appropriate
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disability weight for calculation of the brucellosis DALY. A
systematic review of scientific literature investigating the incidence
and prevalence of brucellosis globally is the subject of a companion
paper [7].
Methods
Searching
Thirty three databases were searched for relevant articles using
the search terms of (brucellosis OR malta fever OR brucella
melitensis OR brucella abortus) AND (symptom* OR sequelae*
OR morbidity OR mortality OR transmission mode OR
foodborne), with a publication limitation of 1990–30 June, 2010.
The search term was adapted to the predominate language of the
database. If a database did not allow the combining of Boolean
operators, (18 of 33 databases), ‘brucellosis’ was used as the sole
term.
Reference Manager bibliographic software was used to manage
citations. Duplicate entries were identified by considering the
author, the year of publication, the title of the article, and the
volume, issue and page numbers of the source. In questionable
cases, the abstract texts were compared.
Selection
The articles were sorted by a team of four reviewers with a
combined fluency in English, German, French, and Spanish.
Articles in other languages were noted for future translation,
pending resources.
All reports were classified into one of two categories, based on
their abstracts:
Category 1: Relevant – articles related to human brucellosis
related to brucellosis infection in populations (i.e. disease
frequency) or cases of human brucellosis (i.e. disease morbidity);
Category 2: Irrelevant - articles related to non-human
brucellosis; articles addressing topics not related to the current
review, such as genetics, laboratory diagnostic tests, experimental
laboratory animal studies.
The abstracts of studies belonging to Category 1 and meeting
the following criteria for disease morbidity studies were retained:
published between 1990 and 30 June 2010, at least 10 study
subjects, clinical symptoms/syndromes described, and some
information relating to diagnostic tests provided. Articles relating
to disease frequency and meeting the following criteria were also
retained: published between 1990 and 30 June 2010, at least 100
study subjects drawn from the general population, prevalence or
incidence data included, and some information relating to
diagnostic tests provided. The assessment and classification of
frequency articles will be the subject of a companion paper and
will not be considered further here.
Articles for which the necessary data for classification could not
be obtained were identified for possible future assessment,
according to availability of resources. In general, non peer-
reviewed or review articles, conference proceedings and book
chapters were excluded.
Validity Assessment
After applying the aforementioned screening steps, the full text
of each selected article was retrieved for detailed analysis. Each
article was reviewed by two or three reviewers, and classification
discrepancies were resolved by discussion.
Using a pre-designed Access database, articles were coded
according to the following parameters:
1) Study type
Studies were classified as a prospective case series, a retrospec-
tive case series, a case-control study, or of another type.
2) Study population
The populations studied were grouped according to age
category – children only (,15 years), adults only ($15 years), or
including both children and adults. Additionally, they were coded
according to whether the study population represented the general
population of brucellosis cases in the age category, or only a
specific sub-group.
3) Diagnostic methods
Studies were classified according to their use of microbial
culture to diagnose brucellosis patients. In order for studies to be
included in the review, they had to not only mention culture in
their methods but to also present laboratory results.
4) Overall study quality
Studies were given an overall quality grade of 1, 2, or 3. Quality
1 studies provided data drawn from general brucellosis cases, of
which 75% or more were diagnosed by culture, and had well
described study design and methods. Quality 2 studies also
presented data from general brucellosis cases, utilised culture as a
method and presented relevant laboratory results. However, unlike
for Quality 1 studies, the majority of cases did not have to be
diagnosed by positive culture in order to be included as Quality 2.
Quality 3 studies were either drawn from only a specific sub-group
of brucellosis cases such that general conclusions could not be
drawn, did not use culture as a diagnostic method or failed to
present culture results, or had poorly described study design and
methods such that the quality of the data could not be assured.
Data Extraction
Based on brucellosis literature [8] a comprehensive list of
clinical manifestations associated with brucellosis cases was
developed:
– General: documented fever, sweats, chills, fatigue, headache,
malaise, weight loss, nausea/vomiting
– Abdominal: abdominal pain, splenomegaly, hepatomegaly,
hepatitis
– Musculoskeletal: arthralgia, arthritis, myalgia, back pain,
spondylitis, sacroiliitis
Author Summary
Brucellosis is a bacterial disease transmitted to humans by
consumption of infected, unpasteurised animal milk or
through direct contact with infected animals, particularly
aborted foetuses. The livestock production losses resulting
from these abortions have a major economic impact on
individuals and communities. Infected people often suffer
from a chronic, debilitating illness. This systematic review
on the symptoms of human brucellosis is the first ever
conducted. Using strict exclusion criteria, 57 scientific
articles published between January 1990–June 2010 which
included high quality data were identified. Severe compli-
cations of brucellosis infection were not rare, with 1 case of
endocarditis and 4 neurological cases per 100 patients.
One in 10 men suffered from testicular infection, which can
case sterility. Debilitating conditions such as joint, muscle,
and back pain affected around half of the patients. Given
that most patients had fever, brucellosis poses a diagnostic
challenge in malaria-endemic areas where fever is often
assumed to be malaria. More high quality data is needed
for a more complete understanding of the clinical
manifestations of disease and exposure risks, and to
provide further evidence for policy-makers.
Systematic Review of Human Brucellosis
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– Specific organ involvement: epididymo-orchitis, abortion,
endocarditis, respiratory and neurological signs, cutaneous
changes
Numbers of subjects with each symptom/syndrome were
recorded for each study, as well as the number of male and
female patients. For the sex-related outcomes of epididymo-
orchitis and abortion, the study population was considered to be
only the male and pregnant female sub-groups of the study
population respectively. Information relating to duration of disease
prior to treatment and exposure to potential risk factors were also
recorded wherever provided.
Data Analysis
To calculate the proportion of patients by sex, numbers of male
and female patients were aggregated across all studies as well as
within each age category. 95% confidence intervals were
calculated using the normal approximation to the binomial.
Where appropriate data were available from two or more
studies, pooled proportions of patients with each clinical manifes-
tation were estimated using generalized linear mixed models.
Pooled estimates with 95% confidence intervals were calculated
both within age categories and overall across all studies, using a
Freeman-Tukey double arscine transformation. Homogeneity
across studies was assessed using a Cochrane’s Q test and total
variability due to between-study variation was reflected in the I2
index. The meta-analysis was performed with R statistical software
[9] using the meta package [10]. Additionally, in order to assess
the impact of study design, the same analysis was conducted
according to study type category.
The pooled estimates for proportions of patients with each
clinical manifestation were compared with the disability weights
used in the GBD 2004 study [11]. A disability weight for
brucellosis was then proposed.
Median proportions of patients with exposure to particular risk
factors were calculated. Data relating to duration of illness and
diagnostic delay were recorded. In order to assess the duration of
untreated illness, an additional, non-systematic search for data
prior to the availability of appropriate antibiotics was undertaken
by manually searching library records.
Results
Searching
Table 1 lists the databases searched and the number of hits
obtained for each. A total of 28,824 studies were identified, of
which 59% were duplicates, leaving 11,000 original reports.
Flow of Included Studies
Figure 1 shows a flow diagram of the process for the selection of
articles included in the review. In total, 289 frequency and
morbidity studies were selected, for which full text was available
for 153. However, 14 of these were in languages in which the team
was not competent (Croatian (6), Turkish (4), Korean (2), Persian
(1), Mandarin (1)), leaving 96 morbidity studies for quality
assessment. Some articles contained both frequency and morbidity
data and were thus counted in both categories.
Of the 96 morbidity studies for quality assessment, five were
classified as Quality 1 and 52 as Quality 2. Thirty-nine were
excluded from further analysis as Quality 3, one of which was due
to duplication of data from another larger study. Two pairs of
Quality 2 studies were based on the same data [12–15]. These
studies were included because each provided some unique
information; however, the duplicated data were only included
once in the meta-analysis. Except for two articles in Spanish and
one in French, all Quality 1 and 2 studies were in English.
Study Characteristics
The median number of study subjects was 143 (IQR: 85-283),
ranging from 20-1028. Studies from high income countries such as
Germany, France, and USA were generally situated at the lower
end of the range (less than 60 subjects), although larger studies
were reported from Spain, including one study of over 900
subjects. Of the 57 studies selected, 24 were from Turkey. The
next most represented country was Saudi Arabia, with 8 studies,
followed by Spain with 4 and Greece with 4. One or two studies
each came from Cuba, France, Germany, Israel, India, Iran,
Jordan, Kuwait, Tunisia, USA, Uzbekistan and Yemen. The
geographic distribution of the selected studies is shown in Figure 2.
In terms of study type, 37 were classified as retrospective case
series with data retrieved from medical records, and 19 as
prospective case series. One study was a case-control. Seventeen
studies provided detailed information about cases with specific
syndromes, e.g. neurological brucellosis [16–19], epididymoor-
chitis [20–23], osteoarticular complications [13,14,24,25], spon-
dylitis [26,27], pulmonary brucellosis [28], pancytopaenia [29],
and pregnant women [30]. As these studies also provided some
information about proportions of general brucellosis cases with
specific symptoms/syndromes, they were included in the review.
Twenty-three studies included both children and adult partic-
ipants [12–15,18,20,24,30–44]. Twelve studies investigated only
children [29,45–55], with an upper age limit ranging from 13
years to 18 years. Of the 19 studies with an adult population of 15
years or older [16,17,21–23,25–27,56–67], five consisted of only
male participants [21–23,64,65]. Three studies did not clearly
state the age category [19,28,68] and were analysed as if
containing data for both adults and children.
Data Analysis
In studies consisting of only children, 64% patients (95% CI:
60–68%) were male. The proportion of male patients in adult
studies was significantly lower, at 56% (95% CI: 55–58%). In
studies including both children and adult patients, 48% were male
(95% CI: 46–51%). Overall, 55% patients (95% CI: 54–56%)
across all studies were male.
Table 2 shows the pooled proportions of patients estimated by
the random-effects model, according to clinical manifestations by
age category. Forest plots are provided as Supplementary
Information. An analysis by study type did not show any
significant changes or trends.
Documented fever was common, with an estimated 78% of
patients affected across the three age categories. Estimates of the
proportions of patients with self-reported symptoms of sweats,
chills, fatigue, headache, and malaise, were significantly lower in
children, ranging from 9–24% depending on symptom, compared
to 33–81% for adults. Weight loss in children, at 13%, was also
lower than the 31% reported in adults.
Abdominal-related manifestations of pain, splenomegaly and
hepatomegaly were fairly uniformly distributed across age
categories, with overall estimated proportions of 19%, 26% and
23%, respectively. The number of studies reporting the presence
of hepatitis was small, totalling only seven, with an estimated 4%
patients affected overall.
Arthralgia was common, affecting 65% patients overall, whereas
arthritis affected only 26% patients. In adult patients, 56% and 49%
suffered from myalgia and back pain, respectively. Only two studies
reported myalgia and back pain in children. Overall, spondylitis and
sacroiliitis were detected in 12–36% adults.
Systematic Review of Human Brucellosis
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In relation to reproductive problems, only one study reported
abortion rates as a proportion of pregnant female participants, which
was 46% [30]. Overall, 10% male patients had epididymo-orchitis.
For more severe outcomes, endocarditis was reported in an
overall 1% patients, and neurological manifestations in 4%.
Neurological outcomes reported included motor deficits, cranial
nerve deficits, sciatica, confusion and/or psychological distur-
bances, meningitis and seizures. 6% of patients suffered from
respiratory manifestations, including cough, bronchopneumonia,
pleural adhesion and pleural adhesion. Cutaneous changes were
reported in 6% patients.
As most studies were case series without a control group, an
evaluation of the importance of risk factors was not possible.
However, median proportions were calculated from 27 studies
which provided some exposure history. Median proportions of
brucellosis cases with exposure to a potential risk factor were 64%
(IQR: 34–78%) for consumption of unpasteurised dairy products,
42% (IQR: 23–59%) for contact with livestock, and 6% (IQR: 3–
19%) for occupational exposure, including veterinarians, butchers,
and abattoir workers. From fifteen studies, the median proportion
of cases with a history of brucellosis in a family member was 20%
(IQR: 17–46%).
Only six studies included in the systematic review provided data
regarding duration of illness prior to diagnosis and treatment
[32,41,52,55,57,62]. The age of the patient and the nature of
the illness were influential factors. One study reported a longer
Table 1. Databases searched and number of hits.
Database Website Hits
Global databases
Medline http://www.ncbi.nlm.nih.gov/sites/pubmed 6176
ISI Web of Science http://isiwebofknowledge.com 3458
EMBASE http://www.embase.com 4980
Popline http://www.popline.org 55
CAB http://www.cabdirect.org 3424
ProMed http://www.promedmail.org 666
The Cochrane Library http://www.thecochranelibrary.com 100
BIOLINE http://www.bioline.org.br 37
WHOLIS http://www.bireme.br 76
Regional WHO databases
African Index Medicus http://indexmedicus.afro.who.int 14
Index Medicus for the Eastern Mediterranean Region http://www.emro.who.int/whalecom0/Library/Databases/wxis.exe/Library/
Databases/iah/
526
Western Pacific Region Index Medicus http://www.wprim.org/ 96
Index Medicus for the South-East Asia Region http://imsear.hellis.org/ 247
Afro Library http://afrolib.afro.who.int/ 2
Other regional databases
Health Information Locator http://www.bireme.br 7
Institute of Tropical Medicine, Antwerp, Belgium http://lib.itg.be:8000/webspirs/start.ws 122
King’s Fund Information & Library Service http://www.kingsfund.org.uk/library/ 0
African Journals Online http://ajol.info/ 71
LILACS http://www.bireme.br 538
MedCarib http://www.bireme.br 9
REPIDISCA http://www.bireme.br 29
PAHO http://www.bireme.br 157
IBECS http://www.bireme.br 148
CUIDEN http://www.index-f.com/ 17
Indian Medlars Center IndMed http://indmed.nic.in/ 84
KoreaMed http://www.koreamed.org/SearchBasic.php 89
Japan Science and Technology Information Aggregator http://www.jstage.jst.go.jp/search/?typej = on&typep = on&typer = on&search = 1 137
Health Research and Development Information Network http://www.herdin.ph/ 0
Panteleimon http://www.panteleimon.org/maine.php3 6
l’Ecole Nationale de la Sante´ Publique http://test.bdsp.ehesp.fr/Base/ 191
La Bibliota`gue de Sante´ Tropicale http://www.santetropicale.com/resume/catalogue.asp 0
System for Information on Grey Literature in Europe http://opensigle.inist.fr 474
Swiss Tropical and Public Health Institute, Human and Animal
Health Unit, electronic departmental reference library
6906
doi:10.1371/journal.pntd.0001929.t001
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duration of illness in adults compared to children under 15 years,
averaging 8 weeks versus 4 weeks, respectively [41]. In another
study, the average duration of illness prior to diagnosis and treatment
was 40 days, but cases with osteoarticular disease generally
experienced longer periods of illness, extending to 6 months [62].
The GBD 2004 study estimated the disability weights for low back
pain due to chronic intervertebral disc disease and osteoarthritis of
the knee to be 0.121 (range 0.103–0.125) and 0.129 (range 0.118–
0.147), respectively [11]. Given the high proportion of patients in
our systematic review with joint, back, or muscular pain, a disability
weight of at least 0.150 is proposed as a minimum estimate for
localised, chronic brucellosis. Generalised, non-specific clinical
manifestations were also common. Acute, non-localised brucellosis
could be approximated by an episode of malaria, estimated to be
0.191 (range 0.172–0.211) by the GBD 2004 study [11].
Discussion
The clinical picture of brucellosis presented in this systematic
review is consistent with other literature [69]. Although a large
amount of data are available regarding clinical manifestations of
brucellosis, its geographical distribution is limited. No high quality
studies were identified from Sub-Saharan Africa, Central and
South America or South-East Asia. This could potentially reflect
either a lower disease burden or a poorer brucellosis surveillance
system.
The proportion of male patients was greater than female
patients amongst both children and adults. Although this
difference was only small in adults, it was more pronounced in
children. Possible explanations could be a greater risk of exposure
amongst boys, with household responsibilities such as shepherding
Figure 1. Flow of selected studies. *Some morbidity studies were also classified as frequency studies.
doi:10.1371/journal.pntd.0001929.g001
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of livestock being preferentially delegated to boys, or gender-
related differences in accessing to health care.
Given the high proportion of brucellosis cases with fever,
brucellosis should be considered as a differential diagnosis for
fevers of unknown origin. In malaria-endemic countries, fever
patients are often diagnosed and treated for malaria based solely
on clinical findings [70]. Improved diagnostic capacity would
reduce the diagnostic delay and facilitate prompt and appropriate
treatment. These health service inadequacies are compounded by
socioeconomic factors, with brucellosis affecting poor, margin-
alised communities who often do not have the means to seek
treatment. Although studies included in this systematic review did
not investigate health-seeking behaviour, a study from rural
Tanzania revealed that 1 in 5 patients did not present to a health
centre for assessment until more than one year after the onset of
illness. Once at the health centre, nearly half (45%) were not
diagnosed with brucellosis at their first visit [71]. In children,
particularly, under-diagnosis of brucellosis is likely. The lower
proportions of reported general symptoms such as sweats, chills,
fatigue, and headache in study populations consisting only of
children in this systematic review could reflect difficulty in
obtaining accurate case histories from this group.
One in 10 men experienced epididymo-orchitis, the most
common genitourinary complication of brucellosis infection. This
can have serious repercussions such as abscessation and infertility.
Although other severe outcomes were less common, 4 neurological
cases and 1 endocarditis case per 100 brucellosis patients were
reported, which is substantial.
Arthralgia, myalgia, and back pain were common manifesta-
tions. The relative lower proportions of patients with sacroiliitis
and spondylitis compared to those reporting back pain might
reflect limitations in diagnostic capacity. Chronic pain has been
shown to severely affect the quality of sufferers’ social and working
lives [72]. As the majority of the brucellosis disease burden is in
less developed countries, where livelihoods are often reliant on
physical activities, the impact of musculoskeletal pain and
impaired function in these settings may be even more serious.
One study reported that patients with osteoarticular disease
experienced a greater diagnostic delay than other cases [62],
reflecting the chronic debilitation that can result from brucellosis
infection. Indeed, in an endemic area of Russia prior to the
availability of effective antibiotic therapies approximately 40% of
1,000 brucellosis cases followed over a 20 year period continued to
suffer from clinical manifestations two years after disease onset. In
this study, cited by Wund in 1966, approximately 90% of cases
had self-cured after 6 years. [73].
Given the complexity of the clinical manifestations of brucellosis,
summarising its impact into a single disability weight risks being too
reductionist. However, a disability weight is required for an
assessment of the global burden of disease which is, in turn,
essential for engagement of policy-makers and funding bodies.
Using the disability classes formerly used by the GBD 2004 study
[74], a disability weight of 0.2 has been previously proposed based
on Mongolian patient data [3]. This estimate fell between Class 1
(0.096), which referred to a limited ability to perform at least one
activity in the one of the following areas: recreation, education,
procreation or occupation; and Class 2 (0.22), referring to a limited
ability to perform most activities in one of the aforementioned areas.
Based on this systematic review and meta-analysis, better
informed estimates of disability weights are proposed: at least
0.150 for chronic, localised brucellosis and 0.190 for acute
brucellosis. However, as this is the first informed estimate of a
brucellosis disability weight, there is a need for further debate
amongst brucellosis experts and a consensus to be reached.
Research Agenda
Morbidity could vary geographically according to epidemiological
setting. Well designed epidemiological studies from regions under-
represented in this review would greatly contribute to an overall
assessment of the global disease burden. A surveillance system amongst
fever patients in malaria-endemic countries could be particularly
informative. Additionally, risk factors for disease should be investigated
through case-control studies. This would provide invaluable informa-
tion to guide disease control interventions and policy.
Limitations
Studies for which a title or abstract was not published in a
language using the Latin alphabet, such as those published only in
Figure 2. Geographical distribution of selected studies.
doi:10.1371/journal.pntd.0001929.g002
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Chinese characters or Arabic script, may not have been identified
during the original database search. Of the foreign language
studies that were identified, those published in languages in which
the team was not competent were excluded from the analysis. It is
possible that some of these studies contained data that could have
contributed to this global assessment of brucellosis morbidity.
Additionally, although studies in English were independently
reviewed by three team members, this was not always possible for
studies reviewed in other languages (German, French, Spanish).
There were likely some differences between the case definitions and
diagnostic capacity of different studies. For neurological and respira-
tory syndromes, many studies provided only an overall aggregated
estimate without details of the different disease forms. A respiratory
case could potentially vary from a patient with only a cough to severe
bronchopneumonia, or a neurological case from altered behaviour and
confusion to nerve deficits, meningitis or seizures. All patients were
positive by culture in only 3 studies. Given the complexity of brucellosis
serology interpretation, it is possible that some patients in other studies
were misdiagnosed as cases of active brucellosis.
The studies provide data from brucellosis patients presenting to
health centres. It is possible that cases that do not present to health
centres are less severe. The results of this review may, therefore, be
biased towards more severe cases. As with the estimation of other
disability weights, the proposed brucellosis disability weight
estimate assumes that a given clinical manifestation will result in
the same disability in all settings, which is unlikely [75].
Conclusion
This systematic review adds to the understanding of the global
burden of brucellosis, one of the most common and important
zoonotic diseases worldwide. Brucellosis is shown to have a severe,
debilitating, and often chronic impact on its sufferers. Significant
delays in appropriate diagnosis and treatment are the result of
both health system inadequacies and socioeconomic factors. Well
designed epidemiological studies from those regions identified to
be lacking in data would allow a better understanding of the
clinical manifestations of disease and exposure risks and provide
further evidence for policy-makers. Based on the findings of this
systematic review and the disability weights from the 2004 Global
Burden of Disease Study, a disability weight of 0.150 is proposed
as the first informed estimate for chronic, localised brucellosis and
0.190 for acute brucellosis. As this is the first informed estimate of
Table 2. Meta-analysis of clinical manifestations of brucellosis by age category.
Manifestation Age Category All studies
Children Adults All Ages
General n % (95% CI) n % (95% CI) n % (95% CI) n % (95% CI)
Fever 7 82 (69; 91) 10 73 (59; 85) 9 79 (49; 97) 26 78 (66; 87)
Sweats 8 23 (11; 37) 14 55 (35; 74) 12 73 (60; 85) 34 54 (42; 66)
Chills 4 18 (9; 29) 5 47 (34; 60) 7 60 (34; 83) 16 45 (30; 61)
Fatigue 2 19 (13; 23) 2 33 (13; 100) 5 51 (27; 75) 9 39 (16; 65)
Headache 6 9 (5; 15) 11 34 (19; 50) 11 52 (32; 72) 28 35 (24; 46)
Malaise 2 24 (16; 34) 6 81 (71; 89) 8 74 (48; 93) 16 71 (57; 83)
Nausea/vomiting 0 - 5 16 (5; 31) 6 26 (15; 38) 11 26 (15; 38)
Weight loss 3 13(8;18) 4 31 (15; 50) 7 29 (15; 47) 14 26 (17; 36)
Abdominal
Abdominal pain 3 14 (1; 38) 4 9 (1; 22) 9 26 (13; 41) 16 19 (11; 29)
Splenomegaly 9 31 (19; 43) 13 24 (18; 31) 14 25 (17; 34) 36 26 (21; 31)
Hepatomegaly 10 27 (15; 41) 13 22 (16; 26) 14 22 (15; 29) 37 23 (19; 27)
Hepatitis 1 1 (0; 5)* 2 8 (1; 38) 4 3 (1; 6) 7 4 (1; 9)
Musculoskeletal
Arthralgia 9 71 (56; 84) 12 65 (49; 79) 16 62 (52; 70) 37 65 (58; 72)
Arthritis 7 41 (18; 65) 5 13 (3; 28) 14 25 (17; 34) 26 26 (19; 34)
Myalgia 2 18 (11; 26) 5 56 (38; 75) 8 49 (36; 63) 15 47 (38; 57)
Back pain 1 10 (3; 21)* 11 49 (31; 67) 11 45 (31; 60) 23 45 (34; 56)
Sacroiliitis 4 6 (3; 10) 3 32 (20; 46) 9 14 (7; 22) 16 15 (9; 22)
Spondylitis 1 18 (1; 28)* 6 12 (7, 19) 9 11 (6; 18) 16 12 (8; 17)
Specific organs
Epididymo-orchitis 1 10 (1; 32)* 10 10 (7; 15) 10 9 (6; 13) 21 10 (7; 13)
Endocarditis 2 3 (1; 6) 6 2 (1; 3) 7 1 (1; 2) 15 2 (1; 2)
Neurological 5 2 (1; 4) 11 5 (3; 7) 10 4 (2; 6) 26 4 (3; 5)
Respiratory 3 5 (1; 14) 5 2 (1; 5) 11 9 (4; 14) 19 6 (3; 9)
Cutaneous 6 5 (2; 10) 4 4 (1; 11) 7 8 (4; 14) 17 6 (4; 9)
*One study only, with a binomial 95% confidence interval.
Pooled proportions of patients with each manifestation are presented as percentages with 95% confidence intervals. The numbers of studies (n) contributing to each
estimate are given.
doi:10.1371/journal.pntd.0001929.t002
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a disability weight for brucellosis, there is a need for further debate
amongst brucellosis experts and a consensus to be reached.
Supporting Information
Checklist S1 PRISMA checklist.
(DOC)
Figure S1 Forest plot for fever.
(TIFF)
Figure S2 Forest plot for sweats.
(TIFF)
Figure S3 Forest plot for chills.
(TIFF)
Figure S4 Forest plot for fatigue.
(TIFF)
Figure S5 Forest plot for headache.
(TIFF)
Figure S6 Forest plot for malaise.
(TIFF)
Figure S7 Forest plot for nausea/vomiting.
(TIFF)
Figure S8 Forest plot for weight loss.
(TIFF)
Figure S9 Forest plot for abdominal pain.
(TIFF)
Figure S10 Forest plot for splenomegaly.
(TIFF)
Figure S11 Forest plot for hepatomegaly.
(TIFF)
Figure S12 Forest plot for hepatitis.
(TIFF)
Figure S13 Forest plot for arthralgia.
(TIFF)
Figure S14 Forest plot for arthritis.
(TIFF)
Figure S15 Forest plot for myalgia.
(TIFF)
Figure S16 Forest plot for back pain.
(TIFF)
Figure S17 Forest plot for sacroiliitis.
(TIFF)
Figure S18 Forest plot for spondylitis.
(TIFF)
Figure S19 Forest plot for epididymo-orchitis.
(TIFF)
Figure S20 Forest plot for endocarditis.
(TIFF)
Figure S21 Forest plot for neurological sequelae.
(TIFF)
Figure S22 Forest plot for respiratory sequelae.
(TIFF)
Figure S23 Forest plot for cutaneous sequelae.
(TIFF)
Acknowledgments
We gratefully acknowledge the support provided by Dr Jalil Darkhan.
Author Contributions
Conceived and designed the experiments: LC HG JZ. Performed the
experiments: ASD LC HG JZ. Analyzed the data: ASD JH ES JZ. Wrote
the paper: ASD LC JH ES JZ.
References
1. Ariza J, Bosilkovski M, Cascio A, Colmenero J, Corbel M, et al. (2007)
Prospectives for the Treatment of Brucellosis in the 21st Century: The Ioannina
Recommendations. PLoS Medicine 4: e317. doi:10.1371/journal.pmed.0040317.
2. Corbel M (2006) Brucellosis in Humans and Animals: FAO, OIE, WHO.
Available:http://www.who.int/csr/resources/publications/Brucellosis.pdf.
3. Roth F, Zinsstag J, Orkhon D, Chimid-Ochir G, Hutton G, et al. (2003) Human
health benefits from livestock vaccination for brucellosis: case study. Bulletin of
the World Health Organization 81: 867–876.
4. Perry B (2002) Ch. 7 - Animal disease impact on the poor: study results.
Investing in Animal Research to Alleviate Poverty. Nairobi: International
Livestock Research Institute. pp 67–78.
5. Global Burden of Disease and Risk Factors (2006). Washington: World Bank. p.
6. World Health Organization (2006) The Control of Neglected Diseases: A route
to poverty alleviation. Available:http://www.who.int/zoonoses/Report_Sept06.
pdf.
7. Dean A, Crump L, Greter H, Schelling E, Zinsstag J (2012) Global burden of
human brucellosis: a systematic review of disease frequency. PLoS Neglected
Tropical Diseases 6: e1865. doi:10.1371/journal.pntd.0001865.
8. Madkour M (2001) Madkour’s Brucellosis. 2nd ed. Germany: Springer. 306 p.
9. R Development Core Team (2012) R: A language and environment for
statistical computing. Vienna, Austria: R Foundation for Statistical Computing.
Available:http://www.R-project.org.
10. Schwarzer G (2012) meta: Meta-Analysis with R. R package version 2.1-1.
Available:http://CRAN.R-project.org/package = meta.
11. Global Burden of Disease 2004 Update: Disability Weights for Diseases and
Conditions (2004). Available:http://www.who.int/healthinfo/global_burden_
disease/GBD2004_DisabilityWeights.pdf.
12. Pourbagher MA, Pourbagher A, Savas L, Turunc T, Demiroglu YZ, et al. (2006)
Clinical pattern and abdominal sonographic findings in 251 cases of brucellosis
in southern Turkey 1002. AJR Am J Roentgenol 187: W191–W194 (b).
doi:10.2214/AJR.05.0241.
13. Pourbagher A, Pourbagher MA, Savas L, Turunc T, Demiroglu YZ, et al. (2006)
Epidemiologic, clinical, and imaging findings in brucellosis patients with
osteoarticular involvement. AJR Am J Roentgenol 187: 873–880 (a).
doi:10.2214/AJR.05.1088.
14. Colmenero JD, Reguera JM, Fernandez-Nebro A, Cabrera-Franquelo F (1991)
Osteoarticular complications of brucellosis. Ann RheumDis 50: 23–26.
15. Colmenero JD, Reguera JM, Martos F, Sanchez-De-Mora D, Delgado M, et al.
(1996) Complications associated with Brucella melitensis infection: a study of 530
cases. Medicine (Baltimore) 75: 195–211.
16. Yetkin MA, Bulut C, Erdinc FS, Oral B, Tulek N (2006) Evaluation of the
clinical presentations in neurobrucellosis. Int J Infect Dis 10: 446–452.
doi:10.1016/j.ijid.2006.05.007.
17. Bodur H, Erbay A, Akinci E, Colpan A, Cevik MA, et al. (2003)
Neurobrucellosis in an endemic area of brucellosis. Scand J Infect Dis 35: 94–
97. doi:10.1080/0036554021000027000.
18. McLean DR, Russell N, Khan MY (1992) Neurobrucellosis: clinical and
therapeutic features. Clin Infect Dis 15: 582–590. doi:10.1093/clind/15.4.582.
19. Karaoglan I, Namiduru M, Akcali A, Cansel N (2008) Different manifestations
of nervous system involvement by neurobrucellosis. Neurosciences 13: 283–287.
20. Colmenero JD, Munoz-Roca NL, Bermudez P, Plata A, Villalobos A, et al.
(2007) Clinical findings, diagnostic approach, and outcome of Brucella melitensis
epididymo-orchitis. Diagn Microbiol Infect Dis 57: 367–372. doi:10.1016/
j.diagmicrobio.2006.09.008.
21. Bayram MM, Kervancioglu R (1997) Scrotal gray-scale and color Doppler
sonographic findings in genitourinary brucellosis. J Clin Ultrasound 25: 443–
447. doi:10.1002/(SICI)1097-0096(199710)25:8,443::AID-JCU6.3.0.CO;2-J.
22. Yetkin MA, Erdinc FS, Bulut C, Tulek N (2005) Epididymoorchitis due to brucellosis
in central Anatolia, Turkey. UrolInt 75: 235–238. doi:10.1159/000087801.
23. Akinci E, Bodur H, Cevik MA, Erbay A, Eren SS, et al. (2006) A complication of
brucellosis: epididymoorchitis. IntJInfectDis 10: 171–177. doi:10.1016/
j.ijid.2005.02.006.
24. Khateeb MI, Araj GF, Majeed SA, Lulu AR (1990) Brucella arthritis: a study of
96 cases in Kuwait. AnnRheumDis 49: 994–998.
25. Tasova Y, Saltoglu N, Sahin G, Aksu HS (1999) Osteoarthricular involvement of
brucellosis in Turkey. Clin Rheumatol 18: 214–219.
Systematic Review of Human Brucellosis
PLOS Neglected Tropical Diseases | www.plosntds.org 8 December 2012 | Volume 6 | Issue 12 | e1929
26. Bodur H, Erbay A, Colpan A, Akinci E (2004) Brucellar spondylitis. Rheumatol
Int 24: 221–226. doi:10.3340/jkns.2008.44.4.277.
27. Yilmaz E, Parlak M, Akalin H, Heper Y, Ozakin C, et al. (2004) Brucellar
Spondylitis: Review of 25 Cases. J Clin Rheumatol 10: 300–307.
28. Hatipoglu CA, Bilgin G, Tulek N, Kosar U (2005) Pulmonary involvement in
brucellosis. J Infect 51: 116–119. doi:10.1016/j.jinf.2004.10.004.
29. Karakukcu M, Patiroglu T, Ozdemir MA, Gunes T, Gumus H, et al. (2004)
Pancytopenia, a rare hematologic manifestation of brucellosis in children.
J Pediatr HematolOncol 26: 803–806.
30. Khan MY, Mah MW, Memish ZA (2001) Brucellosis in pregnant women. Clin
Infect Dis 32: 1172–1177. doi:10.1086/319758.
31. Zaks N, Sukenik S, Alkan M, Flusser D, Neumann L, et al. (1995)
Musculoskeletal manifestations of brucellosis: a study of 90 cases in Israel.
Semin Arthritis Rheum 25: 97–102. doi:10.1016/S0049-0172(95)80022-0.
32. Al Dahouk S, Nockler K, Hensel A, Tomaso H, Scholz HC, et al. (2005) Human
brucellosis in a nonendemic country: a report from Germany, 2002 and 2003.
EurJClinMicrobiolInfectDis 24: 450–456. doi:10.1007/s10096-005-1349-z.
33. Fallatah SM, Oduloju AJ, Al Dusari SN, Fakunle YM (2005) Human brucellosis
in Northern Saudi Arabia. Saudi Med J 26: 1562–1566.
34. Buzgan T, Karahocagil MK, Irmak H, Baran AI, Karsen H, et al. (2010)
Clinical manifestations and complications in 1028 cases of brucellosis: a
retrospective evaluation and review of the literature. Int J Infect Dis 14: e469–
e478. doi:10.1016/j.ijid.2009.06.031.
35. Bukharie HA (2009) Clinical features, complications and treatment outcome of
Brucella infection: Ten years’ experience in an endemic area. TropJPharmRes
8: 303–310.
36. Earhart K, Vafakolov S, Yarmohamedova N, Michael A, Tjaden J, et al. (2009)
Risk factors for brucellosis in Samarqand Oblast, Uzbekistan. Int J Infect Dis 13:
749–753. doi:10.1016/j.ijid.2009.02.014.
37. Troy SB, Rickman LS, Davis CE (2005) Brucellosis in San Diego: epidemiology
and species-related differences in acute clinical presentations. Medicine
(Baltimore) 84: 174–187.
38. Neau D, Bonnet F, Ragnaud JM, Pellegrin JL, Schaeverbeke T, et al. (1997)
Etude re´trospective de 59 cas de brucellose humain en Aquitaine. Aspects
cliniques, biologiques et the´rapeutiques. MedMalInfect 27: 638–641.
39. Savas L, Onlen Y, Savas N, Yapar AF, Aydin M, et al. (2007) Prospective
evaluation of 140 patients with brucellosis in the southern region of Turkey.
InfectDisClinPract 15: 83–88. doi:10.1097/01.idc.0000240863.82188.95.
40. Andriopoulos P, Tsironi M, Deftereos S, Aessopos A, Assimakopoulos G (2007)
Acute brucellosis: presentation, diagnosis, and treatment of 144 cases. Int J Infect
Dis 11: 52–57. doi:10.1016/j.ijid.2005.10.011.
41. Al Shamahy HA, Wright SG (2001) A study of 235 cases of human brucellosis in
Sana’a, Republic of Yemen. East Mediterr Health J 7: 238–246.
42. Gur A, Geyik MF, Dikici B, Nas K, Cevik R, et al. (2003) Complications of
brucellosis in different age groups: a study of 283 cases in southeastern Anatolia
of Turkey. Yonsei Med J 44: 33–44.
43. Shehabi A, Shakir K, el Khateeb M, Qubain H, Fararjeh N, et al. (1990)
Diagnosis and treatment of 106 cases of human brucellosis. J Infect 20: 5–10.
doi:10.1016/S0163-4453(90)92214-6.
44. Alsubaie S, Almuneef M, Alshaalan M, Balkhy H, Albanyan E, et al. (2005)
Acute brucellosis in Saudi families: relationship between brucella serology and
clinical symptoms. IntJInfectDis 9: 218–224. doi:10.1016/j.ijid.2004.07.009.
45. Afsharpaiman S, Mamishi S (2008) Brucellosis: Review of clinical and laboratory
features and therapeutic regimens in 44 children. Acta MedIran 46: 489–494.
doi:10.1016/j.ijid.2009.06.031.
46. Galanakis E, Bourantas KL, Leveidiotou S, Lapatsanis PD (1996) Childhood
brucellosis in north-western Greece: a retrospective analysis. Eur J Pediatr 155:
1–6. doi:10.1007/BF02115616.
47. Gottesman G, Vanunu D, Maayan MC, Lang R, Uziel Y, et al. (1996)
Childhood brucellosis in Israel. Pediatr Infect Dis J 15: 610–615.
48. Citak EC, Citak FE, Tanyeri B, Arman D (2010) Hematologic manifestations of
brucellosis in children: 5 years experience of an anatolian center. J Pediatr
HematolOncol 32: 137–140. doi:10.1097/MPH.0b013e3181ced382.
49. Issa H, Jamal M (1999) Brucellosis in children in south Jordan. East Mediterr
Health J 5: 895–902.
50. Tanir G, Tufekci SB, Tuygun N (2009) Presentation, complications, and
treatment outcome of brucellosis in Turkish children. Pediatr Int 51: 114–119.
doi:10.1111/j.1442-200X.2008.02661.x.
51. Mantur BG, Akki AS, Mangalgi SS, Patil SV, Gobbur RH, et al. (2004)
Childhood brucellosis - a microbiological, epidemiological and clinical study.
J Trop Pediatr 50: 153–157. doi:10.1093/tropej/50.3.153.
52. Shen MW (2008) Diagnostic and therapeutic challenges of childhood brucellosis in a
nonendemic country. Pediatrics 121: e1178–e1183. doi:10.1542/peds.2007-1874.
53. Giannakopoulos I, Nikolakopoulou NM, Eliopoulou M, Ellina A, Kolonitsiou F,
et al. (2006) Presentation of childhood brucellosis in Western Greece. JpnJ Infect
Dis 59: 160–163.
54. Tsolia M, Drakonaki S, Messaritaki A, Farmakakis T, Kostaki M, et al. (2002)
Clinical features, complications and treatment outcome of childhood brucellosis
in central Greece. J Infect 44: 257–262.
55. Shaalan MA, Memish ZA, Mahmoud SA, Alomari A, Khan MY, et al. (2002)
Brucellosis in children: clinical observations in 115 cases. Int J Infect Dis 6: 182–
186.
56. Kokoglu OF, Hosoglu S, Geyik MF, Ayaz C, Akalin S, et al. (2006) Clinical and
laboratory features of brucellosis in two university hospitals in Southeast Turkey.
Trop Doct 36: 49–51. doi:10.1258/004947506775598752.
57. Hizel K, Guzel O, Dizbay M, Karakus R, Senol E, et al. (2007) Age and
duration of disease as factors affecting clinical findings and sacroiliitis in
brucellosis. Infection 35: 434–437. doi:10.1007/s15010-007-6361-z.
58. Elbeltagy KE (2001) An epidemiological profile of brucellosis in Tabuk Province,
Saudi Arabia. East Mediterr Health J 7: 791–798.
59. Demiraslan H, Metan G, Mese EA, Yildiz O, Aygen B, et al. (2009)
Neurobrucellosis: an evaluation of a rare presentation of brucellosis from a
tertiary care centre in Central Anatolia, Turkey. Trop Doct 39: 233–235.
doi:10.1258/td.2009.080430.
60. Tasbakan MI, Yamazhan T, Gokengin D, Arda B, Sertpolat M, et al. (2003)
Brucellosis: a retrospective evaluation. Trop Doct 33: 151–153.
61. Aygen B, Doganay M, Sumerkan B, Yildiz O, Kayabas U (2002) Clinical
manifestations, complications and treatment of brucellosis: a retrospective
evaluation of 480 patients. MedMalInfect 32: 485–493. doi:10.1016/S0399-
077X(02)00403-1.
62. Zribi M, Ammari L, Masmoudi A, Tiouiri H, Fendri C (2009) Clinical
manifestations, complications and treatment of brucellosis: 45 patients study.
PatholBiol 57: 349–352. doi:10.1016/j.patbio.2008.02.003.
63. Abdi-Liae Z, Soudbakhsh A, Jafari S, Emadi H, Tomaj K (2007) Haemato-
logical manifestations of brucellosis. Acta MedIran 45: 145–148.
64. Memish Z, Mah MW, Al Mahmoud S, Al Shaalan M, Khan MY (2000)
Brucella bacteraemia: clinical and laboratory observations in 160 patients.
J Infect 40: 59–63. doi:10.1053/jinf.1999.0586.
65. Celen MK, Ulug M, Ayaz C, Geyik MF, Hosoglu S (2010) Brucellar epididymo-
orchitis in southeastern part of Turkey: an 8 year experience. Braz J Infect Dis
14: 109–115. doi:10.1590/S1413-86702010000100021.
66. Mantur BG, Biradar MS, Bidri RC, Mulimani MS, Veerappa, et al. (2006)
Protean clinical manifestations and diagnostic challenges of human brucellosis in
adults: 16 years’ experience in an endemic area. J Med Microbiol 55: 897–903.
doi:10.1099/jmm.0.46097-0.
67. Pe´rez RP, Pe´rez RP, Basulto MP, Pupo ON, Pena JG, et al. (1997) Estudio
clinico de la brucelosis humana. RevMedUrug Array: 110–117.
68. Barroso GP, Rodriguez-Contreras PR, Gil EB, Maldonado MA, Guijarro HG,
et al. (2002) Estudio de 1.595 casos de brucelosis en la provincia de Almerı´a
(1972–1998) segu´n datos epidemiolo´gicos. RevClinEsp 202: 577–582.
69. Franco M, Mulder M, Gilman R, Smits H (2007) Human brucellosis. Lancet
Infectious Diseases 7: 775–786. doi:10.1016/S1473-3099(07)70286-4.
70. Amexo M, Tolhurst R, Barnish G, Bates I (2004) Malaria misdiagnosis: effects
on the poor and vulnerable. The Lancet 364(9448): 1896–1898.
71. Kunda J, Fitzpatrick J, Kazwala R, French N, Shirima G, et al. (2007) Health-
seeking behaviour of human brucellosis cases in rural Tanzania. BMC Public
Health 7. doi:10.1186/1471-2458-7-315.
72. Breivik H, Collett B, Ventrafridda V, Cohen R, Gallacher D (2006) Survey of
chronic pain in Europe: Prevalence, impact on daily life, and treatment.
European Journal of Pain 10: 287–333. doi:10.1016/j.ejpain.2005.06.009.
73. Wundt W (1968) Krankheiten durch Brucellen. Infektionskrankheiten: Band II,
Krankheiten durch Bakterien. Berlin: Springer-Verlag, Vol. 2. pp 31–554.
74. Murray C (1994) Quantifying the burden of disease: the technical basis for
disability-adjusted life years. Bulletin of the World Health Organization 72: 429–
445.
75. Reidpath D, Allotey P, Kouame A, Cummings R (2003) Measuring health in a
vacuum: examining the disability weight of the DALY. Health Planning and
Policy 18: 351–356. doi:10.1093/heapol/czg043.
Systematic Review of Human Brucellosis
PLOS Neglected Tropical Diseases | www.plosntds.org 9 December 2012 | Volume 6 | Issue 12 | e1929
